Suppr超能文献

择期大手术患者围手术期口腔去污的系统评价和荟萃分析。

A systematic review and meta-analysis of perioperative oral decontamination in patients undergoing major elective surgery.

机构信息

West Midlands Research Collaborative, University of Birmingham, Edgbaston, Birmingham, B15 2TH UK.

Department of Upper Gastro-Intestinal Surgery, Queen Elizabeth Hospital, Birmingham, UK.

出版信息

Perioper Med (Lond). 2016 Mar 22;5:6. doi: 10.1186/s13741-016-0030-7. eCollection 2016.

Abstract

BACKGROUND

Oral antiseptics reduce nosocomial infections and ventilator-associated pneumonia in critically ill medical and surgical patients intubated for prolonged periods. However, the role of oral antiseptics given before and after planned surgery is not clear. The aim of this systematic review and meta-analysis is to determine the effect of oral antiseptics (chlorhexidine or povidone-iodine) when administered before and after major elective surgery.

METHODS

Searches were conducted of the MEDLINE, EMBASE and Cochrane databases. The analysis was performed using the random-effects method and the risk ratio (RR) with 95 % confidence interval (CI).

RESULTS

Of 1114 unique identified articles, perioperative chlorhexidine was administered to patients undergoing elective surgery in four studies. This identified 2265 patients undergoing elective cardiac surgery, of whom 1093 (48.3 %) received perioperative chlorhexidine. Postoperative pneumonia and nosocomial infections were observed in 5.3 and 20.2 % who received chlorhexidine compared to 10.4 and 31.3 % who received a control preparation, respectively. Oral perioperative chlorhexidine significantly reduced the risk of postoperative pneumonia (RR = 0.52; 95 % CI 0.39-0.71; p < 0.01) and overall nosocomial infections (RR = 0.65; 95 % CI 0.52-0.81; p < 0.01), with no effect on in-hospital mortality (RR = 1.01; 95 % CI 0.49-2.09; p = 0.98).

CONCLUSIONS

Perioperative oral chlorhexidine significantly decreases the incidence of nosocomial infection and postoperative pneumonia in patients undergoing elective cardiac surgery. There are no randomised controlled studies of this simple and cheap intervention in patients undergoing elective non-cardiac surgery.

TRIAL REGISTRATION

This systematic review was registered with the International prospective register of systematic reviews (PROSPERO). The registration number is CRD42015016063.

摘要

背景

口服抗菌剂可降低重症监护病房中长期插管的内科和外科患者的医院获得性感染和呼吸机相关性肺炎。然而,计划手术前后给予口服抗菌剂的作用尚不清楚。本系统评价和荟萃分析的目的是确定主要择期手术前后给予口腔抗菌剂(洗必泰或聚维酮碘)的效果。

方法

对 MEDLINE、EMBASE 和 Cochrane 数据库进行了检索。使用随机效应法和风险比(RR)及其 95%置信区间(CI)进行分析。

结果

在 1114 篇独特的文章中,有 4 项研究对接受择期手术的患者进行了围手术期氯己定治疗。这确定了 2265 例接受择期心脏手术的患者,其中 1093 例(48.3%)接受了围手术期氯己定治疗。接受氯己定治疗的患者术后肺炎和医院获得性感染的发生率分别为 5.3%和 20.2%,而接受对照制剂的患者分别为 10.4%和 31.3%。围手术期口服氯己定可显著降低术后肺炎的风险(RR=0.52;95%CI 0.39-0.71;p<0.01)和总医院获得性感染的风险(RR=0.65;95%CI 0.52-0.81;p<0.01),但对住院死亡率无影响(RR=1.01;95%CI 0.49-2.09;p=0.98)。

结论

围手术期口服氯己定可显著降低择期心脏手术患者的医院感染和术后肺炎发生率。尚无关于这种简单廉价的干预措施在择期非心脏手术患者中的随机对照研究。

试验注册

本系统评价已在国际前瞻性系统评价注册库(PROSPERO)中注册。注册号为 CRD42015016063。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1438/4802585/59d76d3c15a4/13741_2016_30_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验